Rohto Pharmaceutical Co. Ltd. announced consolidated earnings results for the first quarter ended June 30, 2021. For the quarter, the company reported net sales were JPY 42,315 million compared to JPY 38,641 million a year ago. Operating income was JPY 6,008 million compared to JPY 3,575 million a year ago. Profit attributable to owners of parent was JPY 4,731 compared to JPY 1,747 million a year ago. Basic net income per share was JPY 41.48 as compared to JPY 15.32 per share a year ago. Diluted net income per share was JPY 41.36 as compared to JPY 15.27 per share a year ago.